Venous Thrombosis (Disorder) (DBCOND0103651)

Identifiers

Synonyms
Thrombosis, Venous / Venous Thrombosis / Venous thrombosis (disorder) / Acute embolism and thrombosis of unspecified vein / Thrombosis venous / Phlebothrombosis / Venous thrombosis NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acenocoumarol
An anticoagulant drug used in the prevention of thromboembolic diseases in infarction and transient ischemic attacks, as well as management of deep vein thrombosis and myocardial infarction.
Dextran
A low molecular weight dextran used as an adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma, as well as the prophylaxis of venous thrombosis and pulmonary embolism during high-risk medical procedures.
No drug targets
Heparin
An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.
Picotamide
A platelet aggregation inhibitor indicated in the treatment of myocardial infarction, thrombosis, cerebrovascular disorders, pulmonary emboli, and atherosclerosis.
No drug targets
Protein C
A medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis.
Warfarin
A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03367364
Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE ProphylaxisNo drug interventionspreventionNot Availablecompleted
NCT06149533
Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patientsprevention3not_yet_recruiting
NCT05710705
Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast ReconstructionNo drug interventionsotherNot Availablerecruiting
NCT06288906
Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy SystemsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04503135
Catheter Associated Asymptomatic Thrombosis in Intensive Care UnitNo drug interventionsNot AvailableNot Availablecompleted
NCT00911157
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patientstreatment3completed
NCT01064362
Hemorrhage Risk Prescribed ArixtraNot AvailableNot Availablecompleted
NCT00843492
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgeryprevention3completed
NCT06440044
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous ThrombembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT06094387
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00443053
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)No drug interventionstreatment3completed
NCT00320398
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)prevention3completed
NCT00312013
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancertreatment3completed
NCT05396157
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06349291
Venous Thrombosis After Removal of Central Venous CatheterNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01444612
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related SurgeryNot AvailableNot Availablecompleted
NCT01691495
ARIXTRA® Adherence in SVT Patients.Not AvailableNot Availablecompleted
NCT04649489
A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer with PVTT, HVTT or IVCTT After Initial Ate/BevNot AvailableNot Availableactive_not_recruiting
NCT06582602
A Study of MK-2060 in Healthy Participants (MK-2060-016)No drug interventionstreatment1not_yet_recruiting
NCT02264964
Duration and Adverse Events of Non-cuffed Catheter in Patients With HemodialysisNo drug interventionspreventionNot Availableunknown_status
NCT02062021
Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT02414802
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous ThrombosistreatmentNot Availableunknown_status
NCT02468102
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)Not AvailableNot Availablecompleted
NCT00457002
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illnessprevention3completed
NCT03895502
Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Studytreatment4completed
NCT00005684
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in ThrombosisNot AvailableNot Availablecompleted
NCT00436787
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteersprevention2completed
NCT00306254
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgeryprevention2completed
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).treatment3completed
NCT03317145
Lower Limb Blood Flow Geko vs Foot PumpNo drug interventionspreventionNot Availablecompleted
NCT03945045
A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVADNo drug interventionspreventionNot Availableunknown_status
NCT01947998
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)Not AvailableNot Availablecompleted
NCT02343198
The Use of NMES as a Home-based Therapy Following Total Knee ArthroplastyNo drug interventionspreventionNot Availableunknown_status
NCT01894997
A Comparison of the Effects of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression on Blood Flow in the Lower LimbNo drug interventionspreventionNot Availablecompleted
NCT01051297
Obstructive Sleep Apnea and Venous ThromboembolismNo drug interventionsNot AvailableNot Availableterminated
NCT00265993
Enoxaparin in Acute Venous Thromboembolic Diseasetreatment4completed
NCT00440193
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Studytreatment3completed
NCT00170378
The Use of Low Molecular Weight Heparin in Traumatic Brain Injuryprevention4completed
NCT02065388
Pharmacogenetic Dosing of WarfarinNo drug interventionstreatment3completed
NCT01086215
Registry of AngioJet Use in the Peripheral Vascular SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT00554632
Birth Control Pill vs Birth Control Patch StudytreatmentNot Availablecompleted
NCT00185952
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.treatmentNot Availablecompleted
NCT01855100
Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)Not AvailableNot Availablecompleted
NCT01947959
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)Not AvailableNot Availablecompleted
NCT00356759
Prolongation of the Interval Between Monitoring of Warfarin in Stable Patientstreatment2completed
NCT01145859
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric SubjectsNot Available1completed
NCT00244270
Cystic Fibrosis and Totally Implantable Vascular Access DevicesNo drug interventionsdiagnostic4completed
NCT00322270
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheterstreatment3completed
NCT00539942
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancyprevention3terminated
NCT02584842
Rivaroxaban in Endovenous Laser Ablation With and Without MiniphlebectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01608906
Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After SurgerypreventionNot Availablecompleted
NCT02597218
Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.No drug interventionsNot AvailableNot Availableunknown_status
NCT05890924
Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in WomenNo drug interventionsNot AvailableNot Availablecompleted
NCT02258958
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00457158
PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava InterruptionNo drug interventionsprevention4completed
NCT00790335
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysistreatment3completed
NCT00839163
Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)treatment2completed
NCT03773939
Risk Prediction of Venous Thromboembolism in Critically IllNo drug interventionsNot AvailableNot Availableunknown_status
NCT00246025
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.prevention2completed
NCT04156230
Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein ThrombosisNo drug interventionsdiagnostic2recruiting
NCT01240330
Vasculaire Compression System Increases Flow Velocity in the Femoral VeinNo drug interventionspreventionNot Availablecompleted
NCT03714048
Blood Management During ECMO for Cardiac SupportNo drug interventionsNot AvailableNot Availablecompleted
NCT01297348
Study Of Lybrel In Relation To Venous ThromboembolismNot AvailableNot Availablecompleted
NCT01779648
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein ThrombosisNo drug interventionspreventionNot Availablecompleted
NCT00878826
Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.prevention2 / 3completed
NCT04889326
Collection of the Thrombo-VaxCov CohortNo drug interventionsNot AvailableNot Availablerecruiting
NCT01252420
Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosistreatment4unknown_status
NCT01482273
Ultrasound-enhanced Thrombolysis Versus Standard Catheter Directed Thrombolysis for Ilio-femoral Deep Vein ThrombosisNo drug interventionstreatmentNot Availablecompleted
NCT02581176
Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Studytreatment4completed
NCT04724460
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With CancerNo drug interventionstreatment4active_not_recruiting
NCT02335580
Effect of Portal Vein Thrombosis on the Prognosis of Liver CirrhosisNot AvailableNot Availablecompleted
NCT01495429
Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive CareNo drug interventionstreatment3completed
NCT02238444
Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomyprevention4unknown_status
NCT00643201
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolismtreatment3completed
NCT00005504
Epidemiology of Venous Thrombosis and Pulmonary EmbolismNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02810704
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacementsupportive_care4recruiting
NCT02247414
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnectiontreatment4completed
NCT05304455
Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal DisconnectionpreventionNot Availablecompleted
NCT04645550
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)prevention4completed
NCT02697123
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03505723
PeriOperative ISchemic Evaluation-3 Trialtreatment3completed
NCT02649023
Deep Venous Thrombosis After Hepatobiliopancreatic SurgeryNo drug interventionsNot AvailableNot Availableterminated
NCT01662908
A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosistreatment2completed
NCT02567903
Tourniquet Study: A Clinical Trial Into the Effect of Tourniquet Use on the Coagulation SystemNo drug interventionspreventionNot Availablecompleted
NCT01413464
The Risk of Venous Clotting in Patients After Renal TransplantNo drug interventionsNot AvailableNot Availableunknown_status
NCT02752984
Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter InsertionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01999179
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosishealth_services_researchNot Availablecompleted
NCT00872079
Personalized Warfarin Dosing by Genomics and Computational IntelligenceNo drug interventionshealth_services_researchNot Availableterminated
NCT01507051
Switching Study From Warfarin to RivaroxabanNot Available1completed
NCT02877251
Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02650453
Ongoing Registry of Deep Venous ReconstructionsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00186745
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney FailuretreatmentNot Availableterminated
NCT02301793
Educating Nurses About Venous Thromboembolism (VTE) PreventionNo drug interventionspreventionNot Availablecompleted
NCT00633893
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolismtreatment3completed
NCT00535171
Venous Thromboembolism Taskforce Audit ProgramNo drug interventionsNot AvailableNot Availablecompleted
NCT01862471
Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood FlowNo drug interventionspreventionNot Availablecompleted
NCT01619007
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyNot AvailableNot Availablecompleted
NCT02651909
Utilization of TEG to Monitor Rivaroxaban ActivityNo drug interventionsNot AvailableNot Availablecompleted
NCT04036656
Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy VolunteersNo drug interventionsprevention1unknown_status
NCT02506985
XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysistreatment4terminated
NCT00521885
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientspreventionNot Availableterminated
NCT01947985
Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)Not AvailableNot Availablecompleted
NCT02767232
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trialtreatment3withdrawn
NCT04732299
Staging and Prognosis of Deep Venous Thrombosis of Lower ExtremitiesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00778336
A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length CathetersNo drug interventionsNot AvailableNot Availablecompleted
NCT00728819
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered CathetersNo drug interventionstreatmentNot Availablecompleted
NCT03328624
A Preliminary Clinical Usability Study for the Recovery Force DVT II CuffNo drug interventionsotherNot Availablecompleted
NCT00346424
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheterstreatment3completed
NCT00203658
Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarintreatment4completed
NCT00162435
Genetic Determinants of Warfarin Anticoagulation EffecttreatmentNot Availableunknown_status
NCT00351663
The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsNo drug interventionsprevention4completed
NCT02867163
Tranexamic Acid and Blood Clots in Knee SurgeryNot AvailableNot Availablecompleted
NCT02064439
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)prevention3completed
NCT00786422
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducertreatment2completed
NCT02268630
Long Term Outcomes of Venous ThromboembolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT00839657
Clarification of Optimal Anticoagulation Through GeneticsNo drug interventionstreatment3completed
NCT00097357
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgeryprevention2 / 3completed
NCT00808626
Phase II Investigation of 99mTc-rBitistatin for Imaging Venous ThrombosisNo drug interventionsdiagnostic1 / 2withdrawn
NCT01736826
Free DNA and Nucleosome Concentrations in Pathological PregnanciesNo drug interventionsNot AvailableNot Availablecompleted
NCT00395265
Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT02892565
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)No drug interventionsscreeningNot Availablecompleted
NCT02161965
Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulationtreatment4completed
NCT03044574
Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous ThromboembolismNo drug interventionspreventionNot Availablecompleted
NCT00687882
Evaluation of the Duration of Therapy for Thrombosis in ChildrenNo drug interventionstreatment3completed
NCT00585182
Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVTprevention4completed
NCT04967573
Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosistreatment3unknown_status
NCT01317160
Compression Treatment Effects on Complications and Healing of Achilles Tendon RuptureNo drug interventionspreventionNot Availablecompleted
NCT02600260
Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical TrialpreventionNot Availablecompleted
NCT04339894
Prospective Epidemiological Study of Upper Limb Venous ThrombosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00621491
Prevention of Venous Thrombosis After Permanent Transvenous Leads ImplantationpreventionNot Availablecompleted
NCT00203580
Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)treatment4completed
NCT04349189
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03001544
Study of Safety and Biomarker Efficacy of TS23 in Healthy VolunteerNo drug interventionstreatment1unknown_status
NCT01805544
Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) IndicationNot AvailableNot Availablecompleted
NCT01164540
Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosistreatment3withdrawn
NCT01042067
Safer Warfarin TreatmentNo drug interventionsNot AvailableNot Availablesuspended
NCT01354704
Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparintreatment4completed
NCT00211146
A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)treatment3completed
NCT01886612
A Comparison of Neuromuscular Electrical Stimulation and Intermittent Pneumatic Compression in Terms of Lower Limb Blood FlowNo drug interventionspreventionNot Availablecompleted
NCT01717495
Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator ProceduresNo drug interventionsNot AvailableNot Availableunknown_status
NCT01406795
The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and StenosesNo drug interventionstreatmentNot Availableterminated
NCT01857050
Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and CephalosporinsNo drug interventionsNot AvailableNot Availablecompleted
NCT01382550
Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.No drug interventionsNot AvailableNot Availableunknown_status
NCT01684423
Oral Rivaroxaban in Children With Venous Thrombosistreatment2completed
NCT02264743
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapytreatment4unknown_status